SPNE - シ―スパイン・ホ―ルディングス (SeaSpine Holdings Corporation)

SPNEのニュース

   "Outlook Moves Modestly Higher" Post Earning - Stifel Reiterates SeaSpine Holdings at Buy with $16 Price Target  2022/08/03 10:09:03 Investing.com
https://www.investing.com/news/pro/outlook-moves-modestly-higher-post-earning--stifel-reiterates-seaspine-holdings-at-buy-with-16-price-target-432SI-2861557
   SeaSpine Holdings Corp (SPNE) CEO Keith Valentine on Q2 2022 Results - Earnings Call Transcript  2022/08/03 03:28:04 Seeking Alpha
SeaSpine Holdings Corp (NASDAQ:NASDAQ:SPNE) Q2 2022 Earnings Conference Call August 02, 2022, 16:30 ET Company Participants Leigh Salvo - Gilmartin Group Keith Valentine - President, CEO…
   SeaSpine Holdings Corporation 2022 Q2 - Results - Earnings Call Presentation (NASDAQ:SPNE)  2022/08/03 03:02:10 Seeking Alpha
The following slide deck was published by SeaSpine Holdings Corporation in conjunction with their 2022 Q2 earnings call.
   Recap: SeaSpine Holdings Q2 Earnings  2022/08/02 21:59:01 Benzinga
SeaSpine Holdings (NASDAQ: SPNE ) reported its Q2 earnings results on Tuesday, August 2, 2022 at 04:05 PM. Here''s what investors need to know about the announcement. Earnings SeaSpine Holdings missed estimated earnings by 8.57%, reporting an EPS of $-0.38 versus an … Full story available on Benzinga.com
   SeaSpine GAAP EPS of -$0.38 misses by $0.03, revenue of $56.3M beats by $1.97M, raises guidance  2022/08/02 20:35:01 Seeking Alpha
SeaSpine press release (SPNE): Q2 GAAP EPS of -$0.38 (vs
   SeaSpine Announces Full Commercial Launch of WaveForm C 3D-printed Interbody System  2022/06/21 20:05:00 Wallstreet:Online
Company’s second fully commercialized interbody system featuring the novel WaveForm 3D printed technology and that addresses an estimated $200 million cervical market opportunity CARLSBAD, Calif., June 21, 2022 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today
   SeaSpine announces full commercial launch of its WaveForm TO product for spinal procedures  2022/06/08 20:30:38 Seeking Alpha
SeaSpine (SPNE), a maker of surgical solutions for the treatment of spinal disorders, on Wednesday announced the full commercial launch of its 3D-printed WaveForm TO Interbody…
   SeaSpine Announces Full Commercial Launch of the WaveForm TO (TLIF Oblique) 3D-Printed Interbody System  2022/06/08 20:05:00 Wallstreet:Online
Company’s first full commercial launch of novel 3D printed interbody product franchise that addresses estimated $500 million market opportunity CARLSBAD, Calif., June 08, 2022 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the full commercial launch of
   3 Med-Tech Stocks With Incredible Potential  2022/05/31 19:28:00 The Motley Fool
Here''s why our roundtable likes iRhythm, SeaSpine Holdings, and Owlet.
   SeaSpine Holdings'' (SPNE) CEO Keith Valentine on Q1 2022 Results - Earnings Call Transcript  2022/05/04 01:51:09 Seeking Alpha
SeaSpine Holdings Corporation (NASDAQ:NASDAQ:SPNE) Q1 2022 Earnings Conference Call May 3, 2022 4:30 PM ET Company Participants Leigh Salvo – Investor Relations Keith Valentine – Chief…
   Financial Analysis: SeaSpine (NASDAQ:SPNE) vs. Femasys (NASDAQ:FEMY)  2021/11/30 06:22:41 ETF Daily News
SeaSpine (NASDAQ:SPNE) and Femasys (NASDAQ:FEMY) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, valuation, risk, analyst recommendations, earnings, dividends and profitability. Profitability This table compares SeaSpine and Femasys net margins, return on equity and return on assets. Net [] The post Financial Analysis: SeaSpine (NASDAQ:SPNE) vs. Femasys (NASDAQ:FEMY) appeared first on ETF Daily News .
   SeaSpine announces full commercial launch of Admiral ACP System  2021/11/23 21:29:42 Seeking Alpha
   SeaSpine Announces Full Commercial Launch of the Admiral ACP System  2021/11/23 21:05:00 Intrado Digital Media
CARLSBAD, Calif., Nov. 23, 2021 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the full commercial launch of its Admiral ACP System. Admiral ACP represents the next generation of anterior cervical plating and was designed to strike the optimal balance between strength, profile and construct rigidity. Differentiated plate features, combined with step-eliminating innovative instrumentation, work seamlessly in the surgeons hands to create a more efficient and consistent anterior cervical discectomy and fusion (ACDF) experience.
   Spinal Posterior Fixation System Market 2021 Size with Top Countries Industry Chain Structure, Competitive Landscape, Future Trends, New Projects and Forecasts up to 2027 - SeaSpine, NuVasive, Silony Medical, B. Braun  2021/11/22 09:18:27 OpenPR
The Spinal Posterior Fixation System Market report is a valuable source of insightful data for business strategists. It provides the industry overview with growth analysis and historical & futuristic cost, revenue, demand, and supply data (as applicable). The research analysts
   Analyzing SeaSpine (NASDAQ:SPNE) & Utah Medical Products (NASDAQ:UTMD)  2021/11/18 15:44:42 Dakota Financial News
SeaSpine (NASDAQ:SPNE) and Utah Medical Products (NASDAQ:UTMD) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, dividends, valuation, analyst recommendations, institutional ownership, profitability and earnings. Risk & Volatility SeaSpine has a beta of 1.12, meaning that its share price is []

calendar